Amlodipine Besylate Tablet
Product Images NDC 70518-3592

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-3592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)
Chemical structure of Amlodipine Besylate, illustrating the molecular arrangement and bonding of its constituent atoms.*
FDA Label Image

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
Kaplan-Meier curve displaying event rate over 24 months comparing Amlodipine and Placebo groups. The x-axis shows time in months, and the y-axis shows event rate. Amlodipine shows a lower event rate than Placebo over time. The graph includes statistical values: P-value 0.003, Hazard Ratio 0.691, 95% Confidence Interval 0.54 to 0.88, and number at risk at various time points.*
FDA Label Image

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
A forest plot chart depicting hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across various patient subgroups, including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis ranges from 0 to 2, indicating the hazard ratio scale, with a vertical line at 1 as the reference point.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Amlodipine Besylate 5 mg tablets, oral dosage form, containing 30 tablets. The label is from RemedyRepack Inc., indicating NDC 70518-3592-00, with manufacturing by Unichem in Ghaziabad, India. Directions refer to the package insert, and storage conditions are specified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.